Clinical trial
Feasibility of OncoTool to Improve Self-Management and Adherence to Oral Anticancer Medications
NCT03952312 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of OncoTool to Improve Self-Management and Adherence to Oral Anticancer Medications
- Lead sponsor
- Northwestern University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 15, 2020
- Completion date
- November 4, 2022
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, cancer, treatment-related, communication, medication adherence, tyrosine kinase inhibitor